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The clonal expansion and malignant transformation of
HTLV-1 infected CD4+ T-cells have been linked to the
reprogramming effects of HTLV-1 on host transcriptional
profile. Coupled to transcription, alternative splicing (AS)
is a post-transcriptional process that plays critical role in
the complexity of transcriptome and splicing abnormal-
ities frequently occur in cancer. To examine whether AS
modifications associate with HTLV-1-associated leukemo-
genesis, we compared the exon expression profiles of
ATL cells with that of CD4+ T-cell clones obtained by
limited-dilution cloning of PBMC deriving from HTLV-1
carriers. 3 ATL cells and 12 untransformed infected
clones clustering in infected, uninfected, PHA-stimulated
or unstimulated CD4+ T cells were compared for exon
RNA content using Exon Chip Human microarray. Hier-
archical clustering analysis identified 12516 alternative
spliced events (3642 genes) that clearly separated ATL
samples from the 4 untransformed phenotypes men-
tioned above. In contrast, the exon content of 1539 genes
differed between untransformed infected and uninfected
T-CD4+ cells. Overall, less than 5% alternatively spliced
genes were found differentially expressed at the transcrip-
tional level. Microarray data were confirmed for 18 AS
events using exon specific RT-PCR analysis. Pathway ana-
lysis of alternatively spliced genes (3642) in ATL cells
revealed new AS-based pathways for p53 signaling, cell
cycle and DNA replication while those of untrans-
formed infected CD4+ T-cells were enriched in path-
ways for cellular movement and DNA repair. These
findings unveil a new layer of complexity in the inter-
play between HTLV-1 and host cell gene expression
machinery in which AS might play a central role in
tumor initiation and promotion.
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